Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma

Two major posttranscriptional mechanisms—alternative splicing (AS) and alternative polyadenylation (APA)—have attracted much attention in cancer research. Nevertheless, their roles in clear cell renal carcinoma (ccRCC) are still ill defined. Herein, this study was conducted to uncover the implicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Weimin, Wu, Yulong, Zhu, Maoshu, Zhong, Hongbin, Huang, Chaoqun, Lin, Yao, Huang, Jiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829526/
https://www.ncbi.nlm.nih.gov/pubmed/35211354
http://dx.doi.org/10.1016/j.omtn.2022.01.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829526/
https://www.ncbi.nlm.nih.gov/pubmed/35211354
http://dx.doi.org/10.1016/j.omtn.2022.01.014

Ejemplares similares